Skip to main content
. 2012 Jun 25;7(6):e39565. doi: 10.1371/journal.pone.0039565

Figure 8. The cyclic AMP analog 8-bromo-cAMP decreased transport of HIV-1 across BMEC (panel A) and at the 0.3 mM dose increased TEER (panel B).

Figure 8

The adenylate cylcase activator forskolin decreased transport of HIV-1 across BMEC (panel C).